We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Game-Changing Scanning Device for Tracking Sample Tubes Eliminates Critical Misplacement Errors

By LabMedica International staff writers
Posted on 13 Apr 2023
Print article
Image: ScanID takes sample traceability to the next level (Photo courtesy of Flow Robotics)
Image: ScanID takes sample traceability to the next level (Photo courtesy of Flow Robotics)

Laboratory errors can significantly impact overall patient care, potentially leading to misdiagnosis and mismanagement. Studies have shown that 24% to 30% of laboratory errors influence patient care, with patient harm occurring in 3% to 12% of cases. Approximately 70% of lab errors occur during the pre-analytical phase, making it the most error-prone part of laboratory testing due to its complex nature and heavy reliance on manual tasks such as pipetting and tracking. Now, a game-changing scanning device for tracking sample tubes aims to resolve this real-life laboratory challenge.

Flow Robotics (Copenhagen, Denmark), the company behind the innovative pipetting robot flowbot ONE, has introduced ScanID, an ultra-efficient scanning device for labs handling barcoded sample tubes. ScanID's patent-pending technology offers both 1D and 2D scanning capabilities in a single device and can scan an entire rack of sample tubes simultaneously in seconds. Once scanned, the racks are placed in the flowbot ONE, which holds all the sample IDs for further processing. ScanID is compatible with a wide range of test tube sizes, ranging from Ø:9mm to Ø:16mm, and fits most SLAS formats.

Manual pre-analytical processes always carry the risk of sample switching and misplacement errors. ScanID can eliminate critical sample misplacement errors and ensure full traceability and documentation with minimal effort. Additionally, ScanID serves as an error control measure by alerting users if two barcodes are similar, providing extra assurance that sample tubes are handled correctly and accurately.

“Our vision with ScanID is to optimize sample traceability. Most labs spend a lot of time and energy on tracking their samples. Whether they are doing the entire thing manually or using a handheld barcode scanner, ScanID will make the process more secure and ensure full traceability with minimum effort,” said Kjetil Kræmer, CTO at Flow Robotics. “Errors due to poor tracking can result in sample switching lead to false outcomes, which can obscure your research and be very difficult to trace. That’s one of the reasons why we believe it’s well worth the effort to automate the process in a secure scanning solution.”

Related Links:
Flow Robotics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.